Therapy for Fibrotic Diseases: Nearing the Starting Line

Exploring the full spectrum of macrophage activation

Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186

Alternative activation of macrophages

Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189

Cellular and molecular mechanisms of fibrosis

Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495

The unfolded protein response: controlling cell fate decisions under ER stress and beyond

Hetz, C. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3270 · Cited by 4,223

Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling

Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101

Mechanisms of fibrosis: therapeutic translation for fibrotic disease

Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541

Mechanisms of Hepatic Fibrogenesis

Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,687

TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES

Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A.-K. L., & Flavell, R. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090737 · Cited by 2,264

Wound repair and regeneration: Mechanisms, signaling, and translation

Eming, S. A., Martin, P., & Tomic-Canic, M. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009337 · Cited by 3,562

Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches

Beermann, J., Piccoli, M.-T., Viereck, J., & Thum, T. (2016) · Physiological Reviews · doi:10.1152/physrev.00041.2015 · Cited by 1,743

Hepatic stellate cells as key target in liver fibrosis

Higashi, T., Friedman, S. L., & Hoshida, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.007 · Cited by 1,485

Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology

Mederacke, I., Hsu, C. C., Troeger, J. S., Huebener, P., Mu, X., Dapito, D. H., Pradere, J.-P., & Schwabe, R. F. (2013) · Nature Communications · doi:10.1038/ncomms3823 · Cited by 1,443

Fibroblasts: Origins, definitions, and functions in health and disease

Plikus, M. V., Wang, X., Sinha, S., Forte, E., Thompson, S. M., Herzog, E. L., Driskell, R. R., Rosenthal, N. A., Biernaskie, J. A., & Horsley, V. (2021) · Cell · doi:10.1016/j.cell.2021.06.024 · Cited by 1,247

Cellular and molecular mechanisms of repair in acute and chronic wound healing

Martin, P. B., & Nunan, R. D. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13954 · Cited by 1,177

TGF-β signaling in health and disease

Massagué, J., & Sheppard, D. (2023) · Cell · doi:10.1016/j.cell.2023.07.036 · Cited by 890

Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis

Liu, F., Lagares, D., Choi, K. M., Stopfer, L., Marinković, A., Vrbanac, V., Probst, C. K., Hiemer, S. E., Sisson, T. H., Horowitz, J. C., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00300.2014 · Cited by 874

TGF-β1 Signaling and Tissue Fibrosis

Kim, K. K., Sheppard, D., & Chapman, H. A. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022293 · Cited by 800

Decoding myofibroblast origins in human kidney fibrosis

Kuppe, C., Ibrahim, M. M., Kranz, J., Zhang, X., Ziegler, S., Perales-Patón, J., Jansen, J., Reimer, K. C., Smith, J. R., Dobie, R., et al. (2021) · Nature · doi:10.1038/s41586-020-2941-1 · Cited by 769

Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets

Di, X., Gao, X., Peng, L., Ai, J., Jin, X., Qi, S., Li, H., Wang, K., & Luo, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01501-9 · Cited by 715

Cellular and molecular mechanisms in kidney fibrosis

Duffield, J. S. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72267 · Cited by 631

Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis

Ding, B.-S., Cao, Z., Lis, R., Nolan, D. J., Guo, P., Simons, M., Penfold, M. E., Shido, K., Rabbany, S. Y., & Rafii, S. (2014) · Nature · doi:10.1038/nature12681 · Cited by 626

Extracellular matrix as a driver of progressive fibrosis

Herrera, J., Henke, C. A., & Bitterman, P. B. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93557 · Cited by 639

The extracellular matrix and transforming growth factor-β1: Tale of a strained relationship

Hinz, B. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.05.006 · Cited by 637

Evolving therapies for liver fibrosis

Schuppan, D., & Kim, Y. O. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66028 · Cited by 610

Determinants of Fibrosis Progression and Regression in NASH

Schuppan, D., Surabattula, R., & Wang, X. Y. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.012 · Cited by 479

TGF-β1 – A truly transforming growth factor in fibrosis and immunity

Lodyga, M., & Hinz, B. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.12.010 · Cited by 467

Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge

Piersma, B., Bank, R. A., & Boersema, M. (2015) · Frontiers in Medicine · doi:10.3389/fmed.2015.00059 · Cited by 465

Myofibroblasts

Hinz, B. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2015.07.009 · Cited by 424

Liver fibrosis: Direct antifibrotic agents and targeted therapies

Schuppan, D., Ashfaq–Khan, M., Yang, A. T., & Kim, Y. O. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.04.006 · Cited by 451

Developmental signalling pathways in renal fibrosis: the roles of Notch, Wnt and Hedgehog

Edeling, M., Ragi, G., Huang, S., Pavenstädt, H. J., & Suszták, K. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.54 · Cited by 443

Mesenchymal stem cells in fibrotic disease

El Agha, E., Kramann, R., Schneider, R. K., Li, X., Seeger, W., Humphreys, B. D., & Bellusci, S. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.07.011 · Cited by 430

Anti–microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways

Gomez, I. G., MacKenna, D. A., Johnson, B. G., Kaimal, V., Roach, A. M., Ren, S., Nakagawa, N., Xin, C., Newitt, R., Pandya, S., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75852 · Cited by 428

Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z

Sciacchitano, S., Lavra, L., Morgante, A., Ulivieri, A., Magi, F., Francesco, G. P. D., Bellotti, C., Salehi, L. B., & Rícci, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020379 · Cited by 387

Hepatic inflammation and progressive liver fibrosis in chronic liver disease

Czaja, A. J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2515 · Cited by 359

The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?

Genovese, F., Manresa, A. A., Leeming, D. J., Karsdal, M. A., & Boor, P. (2014) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-7-4 · Cited by 343

Transforming growth factor β—at the centre of systemic sclerosis

Lafyatis, R. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.137 · Cited by 348

Connective tissue growth factor (CTGF) from basics to clinics

Ramazani, Y., Knops, N., Elmonem, M. A., Nguyen, T. Q., Arcolino, F. O., van den Heuvel, L., Levtchenko, E. N., Kuypers, D. R. J., & Goldschmeding, R. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.007 · Cited by 333

Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis

Tsukui, T., Wolters, P. J., & Sheppard, D. (2024) · Nature · doi:10.1038/s41586-024-07660-1 · Cited by 333

Developmental Heterogeneity of Cardiac Fibroblasts Does Not Predict Pathological Proliferation and Activation

Ali, S. R., Ranjbarvaziri, S., Talkhabi, M., Zhao, P., Subat, A., Hojjat, A., Kamran, P., Mueller, A. M. S., Volz, K. S., Tang, Z., et al. (2014) · Circulation Research · doi:10.1161/circresaha.115.303794 · Cited by 304

The Role of Vascular Smooth Muscle Cells in Arterial Remodeling: Focus on Calcification-Related Processes

Jaminon, A. M. G., Reesink, K. D., Kroon, A. A., & Schurgers, L. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225694 · Cited by 323

The myofibroblast in wound healing and fibrosis: answered and unanswered questions

Bochaton‐Piallat, M., Gabbiani, G., & Hinz, B. (2016) · F1000Research · doi:10.12688/f1000research.8190.1 · Cited by 301

The myofibroblast at a glance

Pakshir, P., Noskovicova, N., Lodyga, M., Son, D. O., Schuster, R., Goodwin, A., Karvonen, H., & Hinz, B. (2020) · Journal of Cell Science · doi:10.1242/jcs.227900 · Cited by 293

Extracellular matrix in lung development, homeostasis and disease

Zhou, Y., Horowitz, J. C., Naba, A., Ambalavanan, N., Atabai, K., Balestrini, J. L., Bitterman, P. B., CORLEY, R. A., Ding, B., Engler, A. J., et al. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.005 · Cited by 299

Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis

Sakai, N., & Tager, A. M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.001 · Cited by 295

The next generation of therapeutics for chronic kidney disease

Breyer, M. D., & Suszták, K. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.67 · Cited by 279

Biology of Hsp47 (Serpin H1), a collagen-specific molecular chaperone

Ito, S., & Nagata, K. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.11.005 · Cited by 272

Functions of Galectin-3 and Its Role in Fibrotic Diseases

Li, L., Li, J., & Gao, J. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.218370 · Cited by 264

Novel insights into the function and dynamics of extracellular matrix in liver fibrosis

Karsdal, M. A., Manon‐Jensen, T., Genovese, F., Kristensen, J. H., Nielsen, M. J., Sand, J. M. B., Hansen, N. U. B., Bay‐Jensen, A., Bager, C. L., Krag, A. A., et al. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00447.2014 · Cited by 265

MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis

Nagpal, V., Rai, R., Place, A. T., Murphy, S. B., Verma, S. K., Ghosh, A. K., & Vaughan, D. E. (2016) · Circulation · doi:10.1161/circulationaha.115.018174 · Cited by 248

MicroRNA mimicry blocks pulmonary fibrosis

Montgomery, R. L., Yu, G., Latimer, P. A., Stack, C., Robinson, K., Dalby, C. M., Kaminski, N., & van Rooij, E. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201303604 · Cited by 238

Novel human hepatic organoid model enables testing of drug-induced liver fibrosis in vitro

Leite, S. B., Roosens, T., El Taghdouini, A., Mannaerts, I., Smout, A. J., Najimi, M., Sokal, E., Noor, F., Chesne, C., & van Grunsven, L. A. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.026 · Cited by 234

The Role of Myofibroblasts in Physiological and Pathological Tissue Repair

Schuster, R., Younesi, F., Ezzo, M., & Hinz, B. (2023) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041231 · Cited by 232

Signalling pathways involved in hypoxia‐induced renal fibrosis

Liu, M., Ning, X., Li, R., Yang, Z. L., Yang, X., Sun, S., & Qian, Q. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13060 · Cited by 223

PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis

Martin, K., Pritchett, J. P., Llewellyn, J., Mullan, A. F., Athwal, V. S., Dobie, R., Harvey, E., Zeef, L. A. H., Farrow, S. N., Streuli, C. H., et al. (2016) · Nature Communications · doi:10.1038/ncomms12502 · Cited by 223

Biomarkers of liver cell death

Eguchi, A., Wree, A., & Feldstein, A. E. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.026 · Cited by 220

Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis

Haak, A. J., Kostallari, E., Sicard, D., Ligresti, G., Choi, K. M., Caporarello, N., Jones, D. L., Tan, Q., Meridew, J. A., Espinosa, A. M. D., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau6296 · Cited by 227

BRD4 is a novel therapeutic target for liver fibrosis

Ding, N., Hah, N., Yu, R. T., Sherman, M. H., Benner, C., Leblanc, M., He, M., Liddle, C., Downes, M., & Evans, R. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522163112 · Cited by 211

Understanding the origin, activation and regulation of matrix‐producing myofibroblasts for treatment of fibrotic disease

Kramann, R., DiRocco, D. P., & Humphreys, B. D. (2013) · The Journal of Pathology · doi:10.1002/path.4253 · Cited by 215

Direct Reprogramming of Hepatic Myofibroblasts into Hepatocytes In Vivo Attenuates Liver Fibrosis

Song, G., Pacher, M., Balakrishnan, A., Yuan, Q., Tsay, H.-C., Yang, D., Reetz, J., Brandes, S., Dai, Z., Pützer, B. M., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.01.010 · Cited by 208

The Mesenteric Fat and Intestinal Muscle Interface: Creeping Fat Influencing Stricture Formation in Crohn’s Disease

Mao, R., Kurada, S. V., Gordon, I. O., Baker, M. E., Gandhi, N. S., McDonald, C., Coffey, J. C., & Rieder, F. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy331 · Cited by 204

The Role of Extracellular Matrix in Skin Wound Healing

Потекаев, Н. Н., Borzykh, O. B., Medvedev, G. V., Pushkin, D. V., Петрова, М. М., Petrov, A. V., Дмитренко, Д. В., Karpova, E. I., Demina, O. M., & Shnayder, N. A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245947 · Cited by 219

Contribution of STAT3 to inflammatory and fibrotic diseases and prospects for its targeting for treatment

Kasembeli, M. M., Bharadwaj, U., Robinson, P., & Tweardy, D. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082299 · Cited by 199

Understanding the impact of fibroblast heterogeneity on skin fibrosis

Griffin, M., desJardins-Park, H. E., Mascharak, S., Borrelli, M. R., & Longaker, M. T. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.044164 · Cited by 198

Therapeutic approaches to control tissue repair and fibrosis: Extracellular matrix as a game changer

Walraven, M., & Hinz, B. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.02.020 · Cited by 199

Drug targeting to myofibroblasts: Implications for fibrosis and cancer

Yazdani, S., Bansal, R., & Prakash, J. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.010 · Cited by 191

Hypothermic oxygenated perfusion (HOPE) protects from biliary injury in a rodent model of DCD liver transplantation

Schlegel, A. A., Graf, R., Clavien, P., & Dutkowski, P. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.06.022 · Cited by 185

Fibroblast-specific inhibition of TGF-β1 signaling attenuates lung and tumor fibrosis

Wei, Y., Kim, T. J., Peng, D. H., Duan, D., Gibbons, D. L., Yamauchi, M., Jackson, J., Saux, C. J. L., Calhoun, C., Peters, J. I., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94624 · Cited by 185

Mechanical regulation of myofibroblast phenoconversion and collagen contraction

Hinz, B., McCulloch, C. A., & Coelho, N. M. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.03.027 · Cited by 182

The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart

Herum, K. M., Lunde, I. G., McCulloch, A. D., & Christensen, G. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6050053 · Cited by 193

Translational strategies and challenges in regenerative medicine

Dimmeler, S., Ding, S., Rando, T. A., & Trounson, A. (2014) · Nature Medicine · doi:10.1038/nm.3627 · Cited by 179

Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis

Leimkühler, N. B., Gleitz, H. F. E., Li, R., Snoeren, I., Fuchs, S. N. R., Nagai, J. S., Banjanin, B., Lam, K. H., Vogl, T., Kuppe, C., et al. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.11.004 · Cited by 175

Deficient Autophagy Results in Mitochondrial Dysfunction and FSGS

Kawakami, T., Gomez, I. G., Ren, S., Hudkins, K., Roach, A., Alpers, C. E., Shankland, S. J., D’Agati, V. D., & Duffield, J. S. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013111202 · Cited by 176

Cellular and Molecular Mediators of Intestinal Fibrosis

Lawrance, I. C., Rogler, G., Bamias, G., Breynaert, C. M., Florholmen, J. R., Pellino, G., Reif, S. S., Speca, S., & Latella, G. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.09.008 · Cited by 179

Molecular biomarkers in idiopathic pulmonary fibrosis

Ley, B., Brown, K. K., & Collard, H. R. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00014.2014 · Cited by 176

PDGFRα signaling drives adipose tissue fibrosis by targeting progenitor cell plasticity

Iwayama, T., Steele, C., Yao, L., Dozmorov, M. G., Karamichos, D., Wren, J. D., & Olson, L. E. (2015) · Genes & Development · doi:10.1101/gad.260554.115 · Cited by 164

Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy

Cai, X., Wang, J., Wang, J., Zhou, Q., Yang, B., He, Q., & Weng, Q. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104720 · Cited by 170

Strategies targeting the IL-4/IL-13 axes in disease

May, R. D., & Fung, M. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.018 · Cited by 166

Mechanotransduction-modulated fibrotic microniches reveal the contribution of angiogenesis in liver fibrosis

Liu, L., You, Z., Yu, H., Zhou, L., Zhao, H., Yan, X., Li, D., Wang, B., Zhu, L., Xu, Y., et al. (2017) · Nature Materials · doi:10.1038/nmat5024 · Cited by 163

Hepatocyte Stress Increases Expression of Yes‐Associated Protein and Transcriptional Coactivator With PDZ‐Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis

Mooring, M., Fowl, B. H., Lum, S. Z. C., Liu, Y., Yao, K., Softic, S., Kirchner, R., Bernstein, A., Singhi, A. D., Jay, D. G., et al. (2020) · Hepatology · doi:10.1002/hep.30928 · Cited by 162

ECM formation and degradation during fibrosis, repair, and regeneration

Mayorca-Guiliani, A. E., Leeming, D. J., Henriksen, K., Mortensen, J. H., Nielsen, S. H., Anstee, Q. M., Sanyal, A. J., Karsdal, M. A., & Schuppan, D. (2025) · npj Metabolic Health and Disease · doi:10.1038/s44324-025-00063-4 · Cited by 176

The role of mouse strain differences in the susceptibility to fibrosis: a systematic review

Walkin, L., Herrick, S. E., Summers, A., Brenchley, P. E., Hoff, C. M., Korstanje, R., & Margetts, P. J. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-18 · Cited by 160

An Exosomal Urinary miRNA Signature for Early Diagnosis of Renal Fibrosis in Lupus Nephritis

Solé, C., Moliné, T., Vidal, M., Ordi‐Ros, J., & Cortés-Hernández, J. (2019) · Cells · doi:10.3390/cells8080773 · Cited by 157

Hepatic Stellate Cells and Hepatocarcinogenesis

Barry, A. E., Baldeosingh, R., Lamm, R. J., Patel, K., Zhang, K., Dominguez, D. A., Kirton, K. J., Shah, A. P., & Dang, H. T. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00709 · Cited by 159

Treatment of Renal Fibrosis—Turning Challenges into Opportunities

Klinkhammer, B. M., Goldschmeding, R., Floege, J., & Boor, P. (2017) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2016.11.002 · Cited by 155

EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling

Park, S.-A., Kim, M.-J., Park, S.-Y., Kim, J.-S., Lee, S., Woo, H. A., Kim, D.-K., Nam, J., & Sheen, Y. Y. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1798-6 · Cited by 156

3D in vitro models of liver fibrosis

van Grunsven, L. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.004 · Cited by 162

Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation

Bárcena, C., Stefanović, M., Tutusaus, A., Joannas, L. D., Menéndez, A., García‐Ruiz, C., Sancho‐Bru, P., Marı́, M., Caballería, J., Rothlin, C. V., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.013 · Cited by 154

Effects of CTGF Blockade on Attenuation and Reversal of Radiation-Induced Pulmonary Fibrosis

Bickelhaupt, S., Erbel, C., Timke, C., Wirkner, U., Dadrich, M., Flechsig, P., Tietz, A., Pföhler, J., Groß, W., Peschke, P., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw339 · Cited by 153

Fibrosis imaging: Current concepts and future directions

Baues, M., Dasgupta, A., Ehling, J., Prakash, J., Boor, P., Tacke, F., Kiessling, F. M., & Lammers, T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.10.013 · Cited by 155

Multipotent stromal cells: One name, multiple identities

Soliman, H., Theret, M., Scott, W., Hill, L., Underhill, T. M., Hinz, B., & Rossi, F. M. V. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.09.001 · Cited by 147

Role and New Insights of Pirfenidone in Fibrotic Diseases

la Mora, D. A. L.-D., Sánchez-Roque, C., Montoya‐Buelna, M., Sánchez‐Enríquez, S., Lucano‐Landeros, S., Macías‐Barragán, J., & Armendáriz‐Borunda, J. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.11579 · Cited by 144

Fibrosis in Ulcerative Colitis

Gordon, I. O., Agrawal, N., Goldblum, J. R., Fiocchi, C., & Rieder, F. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000080 · Cited by 139

Scarring vs. functional healing: Matrix-based strategies to regulate tissue repair

Keane, T. J., Horejs, C., & Stevens, M. M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.02.002 · Cited by 145

Fibrotic microtissue array to predict anti-fibrosis drug efficacy

Asmani, M., Velumani, S., Li, Y., Wawrzyniak, N., Hsia, I., Chen, Z., Hinz, B., & Zhao, R. (2018) · Nature Communications · doi:10.1038/s41467-018-04336-z · Cited by 137

TNF-α–stimulated fibroblasts secrete lumican to promote fibrocyte differentiation

Pilling, D., Vakil, V., Cox, N., & Gomer, R. (2015) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1507387112 · Cited by 132

Bioreactor technologies to support liver function in vitro

Ebrahimkhani, M. R., Neiman, J. A. S., Raredon, M. S. B., Hughes, D. J., & Griffith, L. G. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.02.011 · Cited by 141

Specific hepatic delivery of procollagen α1(I) small interfering RNA in lipid‐like nanoparticles resolves liver fibrosis

Calvente, C. J., Sehgal, A., Popov, Y. V., Kim, Y. O., Zevallos, V. F., Şahin, U., Diken, M., & Schuppan, D. (2015) · Hepatology · doi:10.1002/hep.27936 · Cited by 134

Reversal, maintenance or progression: What happens to the liver after a virologic cure of hepatitis C?

Lee, Y. A., & Friedman, S. L. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.03.012 · Cited by 132

Biomechanics of TGFβ‐induced epithelial‐mesenchymal transition: implications for fibrosis and cancer

O’Connor, J. W., & Gomez, E. W. (2014) · Clinical and Translational Medicine · doi:10.1186/2001-1326-3-23 · Cited by 136

IL-4 Receptor Alpha Signaling through Macrophages Differentially Regulates Liver Fibrosis Progression and Reversal

Weng, S.-Y., Wang, X., Vijayan, S., Tang, Y., Kim, Y. O., Padberg, K., Regen, T., Molokanova, O., Chen, T., Bopp, T., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.01.028 · Cited by 128

Renal erythropoietin-producing cells in health and disease

Souma, T., Suzuki, N., & Yamamoto, M. P. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00167 · Cited by 129

Lung Pericytes and Resident Fibroblasts

Barron, L., Gharib, S. A., & Duffield, J. S. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.07.004 · Cited by 132

Clinical Relevance of Fascial Tissue and Dysfunctions

Klingler, W., Velders, M., Hoppe, K., Pedro, M., & Schleip, R. (2014) · Current Pain and Headache Reports · doi:10.1007/s11916-014-0439-y · Cited by 122

Negative regulators of TGF-β1 signaling in renal fibrosis; pathological mechanisms and novel therapeutic opportunities

Gifford, C. C., Tang, J., Costello, A., Khakoo, N. S., Nguyen, T. Q., Goldschmeding, R., Higgins, P. J., & Samarakoon, R. (2021) · Clinical Science · doi:10.1042/cs20201213 · Cited by 129

Liver fibrosis: Common mechanisms and antifibrotic therapies

Schuppan, D. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.05.005 · Cited by 126

Pathophysiology of Urinary Tract Obstruction

Gulmi, F. A., & Felsen, D. (2012) · Wiley eBooks · doi:10.1002/9781444345148.ch7 · Cited by 122

Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosis

Cao, Z., Ye, T., Sun, Y., Ji, G., Shido, K., Chen, Y., Luo, L., Na, F., Li, X., Huang, Z., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai8710 · Cited by 121

Origins of fibrosis: pericytes take centre stage

Greenhalgh, S. N., Iredale, J. P., & Henderson, N. C. (2013) · F1000Prime Reports · doi:10.12703/p5-37 · Cited by 96

Epigenetics and Fibrosis

Liu, B., Wang, X. S., Chen, H., Lu, Q., Gershwin, M. E., & Leung, P. S. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800957-4.00004-7 · Cited by 1

Molecular Mechanisms of Fibrogenesis in Chronic Diseases of Internal Organs: Biomarkers, Prognostication, and Antifibrotic Therapy

Elena, M. (2026) · Journal of chemical health risks · doi:10.52783/jchr.v16.i4.15790

Fibrosis: cross-organ biology and pathways to development of innovative drugs

Rieder, F., Nagy, L. E., Maher, T. M., Distler, J. H. W., Kramann, R., Hinz, B., & Prunotto, M. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01158-9 · Cited by 134

FibromiRs: translating molecular discoveries into new anti-fibrotic drugs

Pottier, N., Cauffiez, C., Perrais, M., Barbry, P., & Mari, B. P. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.01.003 · Cited by 105

Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies

Chen, X., Zhang, J., Guo, L., Wu, C., Zhou, J., Xu, M., Mo, L., Li, Y., & He, J. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02532-0 · Cited by 40